Nomograms for Predicting the Risk of Arm Lymphedema after Axillary Dissection in Breast Cancer
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Lymphedema (LE) after axillary lymph node dissection (ALND) is a multifactorial, chronic, and disabling condition that currently affects an estimated 4 million people worldwide. Although several risk factors have been described, it is difficult to estimate the risk in individual patients. We therefore developed nomograms based on a large data set.
Clinicopathologic features were collected from a prospective cohort comprising 1,054 women with unilateral breast cancer undergoing ALND as part of their surgical treatment from August 2001 to November 2002. LE was defined as a volume difference of at least 200 ml between arms at 6 months or more after surgery. The cumulative incidence of LE was ascertained by the Kaplan–Meier method, and Cox proportional hazard models were used to predict the risk of developing LE on the basis of the available data at each time point: model 1, preoperatively; model 2, within 6 months from surgery; and model 3, at 6 months or later after surgery.
The 5 year cumulative incidence of LE was 30.3%. Independent risk factors for LE were age, body mass index, ipsilateral arm chemotherapy infusions, level of ALND, location of radiotherapy field, development of postoperative seroma, infection, and early edema. When applied to the validation set, the concordance indices were 0.706, 0.729, and 0.736 for models 1, 2, and 3, respectively.
The proposed nomograms can help physicians and patients predict the 5 year probability of LE after ALND for breast cancer. Free online versions of the nomograms are available at http://www.lymphedemarisk.com/.
- Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2008, Cancer incidence and mortality worldwide. IARC CancerBase No. 10. Lyon, France: International Agency for Research on Cancer; 2010. http://globocan.iarc.fr.
- Cancer facts and figures, 2010. American Cancer Society, Atlanta
- Surveillance, Epidemiology, and End Results. Cancer of the breast (invasive)—estimated United States cancer prevalence counts on January 1, 2007, by race/ethnicity, sex and years since diagnosis (table 4.25). SEER Cancer Statistics Review, 1975–2007. http://seer.cancer.gov/csr/1975_2007/browse_csr.php?section=4&page=sect_04_table.25.html.
- International Data Base (IDB)—World population summary. US Census Bureau, Population Division, December 11, 2010. http://www.census.gov/ipc/www/idb/worldpopinfo.php.
- McLaughlin, SA, Wright, MJ, Morris, KT (2008) Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol. 26: pp. 5213-5219 CrossRef
- Tsai, RJ, Dennis, LK, Lynch, CF, Snetselaar, LG, Zamba, GK, Scott-Conner, C (2009) The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors. Ann Surg Oncol. 16: pp. 1959-1972 CrossRef
- Bevilacqua, JL, Kattan, MW, Fey, JV, Cody, HS, Borgen, PI, Zee, KJ (2007) Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation. J Clin Oncol. 25: pp. 3670-3679 CrossRef
- Voogd, AC, Coebergh, JW, Repelaer van Driel, OJ (2000) The risk of nodal metastases in breast cancer patients with clinically negative lymph nodes: a population-based analysis. Breast Cancer Res Treat. 62: pp. 63-69 CrossRef
- Edwards, TL (2000) Prevalence and aetiology of lymphoedema after breast cancer treatment in southern Tasmania. Aust N Z J Surg. 70: pp. 412-418 CrossRef
- Kuehn, T, Klauss, W, Darsow, M (2000) Long-term morbidity following axillary dissection in breast cancer patients—clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors. Breast Cancer Res Treat. 64: pp. 275-286 CrossRef
- Hojris, I, Andersen, J, Overgaard, M, Overgaard, J (2000) Late treatment-related morbidity in breast cancer patients randomized to postmastectomy radiotherapy and systemic treatment versus systemic treatment alone. Acta Oncol. 39: pp. 355-372 CrossRef
- Johansen, J, Overgaard, J, Blichert-Toft, M, Overgaard, M (2000) Treatment of morbidity associated with the management of the axilla in breast-conserving therapy. Acta Oncol. 39: pp. 349-354 CrossRef
- Schrenk, P, Rieger, R, Shamiyeh, A, Wayand, W (2000) Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer. 88: pp. 608-614 CrossRef
- Isaksson, G, Feuk, B (2000) Morbidity from axillary treatment in breast cancer—a follow-up study in a district hospital. Acta Oncol. 39: pp. 335-336 CrossRef
- Petrek, JA, Senie, RT, Peters, M, Rosen, PP (2001) Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer. 92: pp. 1368-1377 CrossRef
- Freitas, R, Ribeiro, LFJ, Tala, L, Kajita, D, Fernandes, MV, Queiroz, G (2001) Lymphedema in breast cancer patients submitted to modified radical mastectomy. Rev Bras Ginecol Obstet. 23: pp. 205-208 CrossRef
- Ververs, JM, Roumen, RM, Vingerhoets, AJ (2001) Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer. 37: pp. 991-999 CrossRef
- Sener, SF, Winchester, DJ, Martz, CH (2001) Lymphedema after sentinel lymphadenectomy for breast carcinoma. Cancer. 92: pp. 748-752 CrossRef
- Duff, M, Hill, AD, McGreal, G, Walsh, S, McDermott, EW, O’Higgins, NJ (2001) Prospective evaluation of the morbidity of axillary clearance for breast cancer. Br J Surg. 88: pp. 114-117 CrossRef
- Herd-Smith, A, Russo, A, Muraca, MG, Turco, MR, Cardona, G (2001) Prognostic factors for lymphedema after primary treatment of breast carcinoma. Cancer. 92: pp. 1783-1787 CrossRef
- Meric, F, Buchholz, TA, Mirza, NQ (2002) Long-term complications associated with breast-conservation surgery and radiotherapy. Ann Surg Oncol. 9: pp. 543-549 CrossRef
- Almeida, AM, Prado, MAS, Guidorizzi, LLF, Rossini, FP (2002) Mulheres com câncer de mama: estudo de morbidade. Acta Oncol Bras. 22: pp. 263-269
- Beaulac, SM, McNair, LA, Scott, TE, LaMorte, WW, Kavanah, MT (2002) Lymphedema and quality of life in survivors of early-stage breast cancer. Arch Surg. 137: pp. 1253-1257 CrossRef
- Swenson, KK, Nissen, MJ, Ceronsky, C, Swenson, L, Lee, MW, Tuttle, TM (2002) Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer. Ann Surg Oncol. 9: pp. 745-753 CrossRef
- Temple, LK, Baron, R, Cody, HS (2002) Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women. Ann Surg Oncol. 9: pp. 654-662 CrossRef
- Rampaul, RS, Mullinger, K, Macmillan, RD (2003) Incidence of clinically significant lymphoedema as a complication following surgery for primary operable breast cancer. Eur J Cancer. 39: pp. 2165-2167 CrossRef
- Deutsch, M, Flickinger, JC (2003) Arm edema after lumpectomy and breast irradiation. Am J Clin Oncol. 26: pp. 229-231
- Schijven, MP, Vingerhoets, AJ, Rutten, HJ (2003) Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol. 29: pp. 341-350 CrossRef
- Yap, KP, McCready, DR, Narod, S, Manchul, LA, Trudeau, M, Fyles, A (2003) Factors influencing arm and axillary symptoms after treatment for node negative breast carcinoma. Cancer. 97: pp. 1369-1375 CrossRef
- Golshan, M, Martin, WJ, Dowlatshahi, K (2003) Sentinel lymph node biopsy lowers the rate of lymphedema when compared with standard axillary lymph node dissection. Am Surg. 69: pp. 209-211
- Blanchard, DK, Donohue, JH, Reynolds, C, Grant, CS (2003) Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg. 138: pp. 482-487 CrossRef
- Veronesi, U, Paganelli, G, Viale, G (2003) A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 349: pp. 546-553 CrossRef
- Goffman, TE, Laronga, C, Wilson, L, Elkins, D (2004) Lymphedema of the arm and breast in irradiated breast cancer patients: risks in an era of dramatically changing axillary surgery. Breast J. 10: pp. 405-411 CrossRef
- Deo, SV, Ray, S, Rath, GK (2004) Prevalence and risk factors for development of lymphedema following breast cancer treatment. Indian J Cancer. 41: pp. 8-12
- Ozaslan, C, Kuru, B (2004) Lymphedema after treatment of breast cancer. Am J Surg. 187: pp. 69-72 CrossRef
- Silberman, AW, McVay, C, Cohen, JS (2004) Comparative morbidity of axillary lymph node dissection and the sentinel lymph node technique: implications for patients with breast cancer. Ann Surg. 240: pp. 1-6 CrossRef
- Armer, J, Fu, MR, Wainstock, JM, Zagar, E, Jacobs, LK (2004) Lymphedema following breast cancer treatment, including sentinel lymph node biopsy. Lymphology. 37: pp. 73-91
- Veen, P, Voogdt, N, Lievens, P, Duquet, W, Lamote, J, Sacre, R (2004) Lymphedema development following breast cancer surgery with full axillary resection. Lymphology. 37: pp. 206-208
- Bergmann, A (2004) Diagnóstico de linfedema: análise dos métodos empregados na avaliação do membro superior após linfadenectomia axilar para tratamento do câncer de mama. Rev Bras Cancerol. 50: pp. 311-320
- Bergmann, A, Koifman, RJ, Ribeiro, MJP, Mattos, IE (2007) Upper limb lymphedema following breast cancer surgery: prevalence and associated factors. Lymphology. 40: pp. 96-106
- Bergmann A. Incidência e fatores de risco do linfedema após tratamento cirúrgico para câncer de mama: Estudo de uma coorte hospitalar. Rio de Janiero: Escola Nacional de Saúde Pública, Fundação Oswaldo Cruz; 2005.
- Leidenius, M, Leivonen, M, Vironen, J, Smitten, K (2005) The consequences of long-time arm morbidity in node-negative breast cancer patients with sentinel node biopsy or axillary clearance. J Surg Oncol. 92: pp. 23-31 CrossRef
- Rönkä, R, Smitten, K, Tasmuth, T, Leidenius, M (2005) One-year morbidity after sentinel node biopsy and breast surgery. Breast. 14: pp. 28-36 CrossRef
- Clark, B, Sitzia, J, Harlow, W (2005) Incidence and risk of arm oedema following treatment for breast cancer: a three-year follow-up study. QJM. 98: pp. 343-348 CrossRef
- Mansel, RE, Fallowfield, L, Kissin, M (2006) Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. J Natl Cancer Inst. 98: pp. 599-609 CrossRef
- Langer, I, Guller, U, Berclaz, G (2007) Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients. Ann Surg. 245: pp. 452-461 CrossRef
- Lucci, A, McCall, LM, Beitsch, PD (2007) Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol. 25: pp. 3657-3663 CrossRef
- McLaughlin, SA, Wright, MJ, Morris, KT (2008) Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors. J Clin Oncol. 26: pp. 5220-5226 CrossRef
- Armer, JM, Radina, ME, Porock, D, Culbertson, SD (2003) Predicting breast cancer–related lymphedema using self-reported symptoms. Nurs Res. 52: pp. 370-379 CrossRef
- Bani, HA, Fasching, PA, Lux, MM (2007) Lymphedema in breast cancer survivors: assessment and information provision in a specialized breast unit. Patient Educ Couns. 66: pp. 311-318 CrossRef
- Clark GM. Prognostic and Predictive Factors. In: Harris JR, Lippman ME, Morrow M, Osborne CK, editors. Diseases of the breast. Philadelphia: Lippincott Williams & Wilkins; 1996. p. 461–85.
- Coen, JJ, Taghian, AG, Kachnic, LA, Assaad, SI, Powell, SN (2003) Risk of lymphedema after regional nodal irradiation with breast conservation therapy. Int J Radiat Oncol Biol Phys. 55: pp. 1209-1215 CrossRef
- Hinrichs, CS, Watroba, NL, Rezaishiraz, H (2004) Lymphedema secondary to postmastectomy radiation: incidence and risk factors. Ann Surg Oncol. 11: pp. 573-580 CrossRef
- Johansson, K, Ohlsson, K, Ingvar, C, Albertsson, M, Ekdahl, C (2002) Factors associated with the development of arm lymphedema following breast cancer treatment: a match pair case-control study. Lymphology. 35: pp. 59-71
- Langer, S, Guenther, JM, Haigh, PI, DiFronzo, LA (2004) Lymphatic mapping improves staging and reduces morbidity in women undergoing total mastectomy for breast carcinoma. Am Surg. 70: pp. 881-885
- Mathew, J, Barthelmes, L, Neminathan, S, Crawford, D (2006) Comparative study of lymphoedema with axillary node dissection versus axillary node sampling with radiotherapy in patients undergoing breast conservation surgery. Eur J Surg Oncol. 32: pp. 729-732 CrossRef
- Meeske, KA, Sullivan-Halley, J, Smith, AW (2009) Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women. Breast Cancer Res Treat. 113: pp. 383-391 CrossRef
- Moskovitz, AH, Anderson, BO, Yeung, RS, Byrd, DR, Lawton, TJ, Moe, RE (2001) Axillary web syndrome after axillary dissection. Am J Surg. 181: pp. 434-439 CrossRef
- Casley-Smith, JR (1994) Measuring and representing peripheral oedema and its alterations. Lymphology. 27: pp. 56-70
- Clarke, D, Martinez, A, Cox, RS, Goffinet, DR (1982) Breast edema following staging axillary node dissection in patients with breast carcinoma treated by radical radiotherapy. Cancer. 49: pp. 2295-2299 CrossRef
- Mathers C, Fat DM, Boerma JT, World Health Organization. The global burden of disease 2004 update. Geneva: World Health Organization; 2008.
- Pisano, ED, Gatsonis, C, Hendrick, E (2005) Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med. 353: pp. 1773-1783 CrossRef
- Giuliano, AE, McCall, L, Beitsch, P (2010) Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg. 252: pp. 426-432
- Giuliano, AE, Hunt, KK, Ballman, KV (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 305: pp. 569-575 CrossRef
- Weber, WP, Barry, M, Stempel, MM (2012) A 10-year trend analysis of sentinel lymph node frozen section and completion axillary dissection for breast cancer: are these procedures becoming obsolete?. Ann Surg Oncol. 19: pp. 225-232 CrossRef
- National Comprehensive Cancer Network (NCCN). Clinical practice guidelines in oncology, version 2, 2011. http://www.nccn.org/.
- Baker, A, Kim, H, Semple, JL (2010) Experimental assessment of pro-lymphangiogenic growth factors in the treatment of post-surgical lymphedema following lymphadenectomy. Breast Cancer Res. 12: pp. R70 CrossRef
- Nomograms for Predicting the Risk of Arm Lymphedema after Axillary Dissection in Breast Cancer
Annals of Surgical Oncology
Volume 19, Issue 8 , pp 2580-2589
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Escola Nacional de Saúde Pública/FIOCRUZ, Rio de Janeiro, Brazil
- 2. Hospital Sirio-Libanes, Sao Paulo, Brazil
- 3. Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA
- 4. Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil
- 5. Centro Universitario Augusto Motta-UNISUAM, Rio de Janeiro, Brazil